Skip to content
Back to skills

Ata Gh Pregnancy Discontinuation

ASecurity

Suggests discontinuing growth hormone (GH) replacement during pregnancy due to lack of clear evidence for efficacy or safety and placental GH production. Triggers include managing a pregnant patient on GH replacement.

  • 12 stars
  • 0 votes
  • 0 copies
  • 1 view
  • Added September 9, 2026
researchrails

Works with

  • cli

Security analysis

A100/100

Scanned September 9, 2026

npx -y skills add dromlakhani/MD2SKILL --skill ata-gh-pregnancy-discontinuation --agent claude-code

Installs into .claude/skills of the current project.

Are you the author of Ata Gh Pregnancy Discontinuation?

Add the live security badge to your README. It updates with every re-scan.

Security grade badge for Ata Gh Pregnancy Discontinuation
[![Security: A — Skills Directory](https://www.skillsdirectory.com/api/skills/dromlakhani-ata-gh-pregnancy-discontinuation/badge)](https://www.skillsdirectory.com/skills/dromlakhani-ata-gh-pregnancy-discontinuation)

More formats (shields.io, HTML) on the badges page. Keep it an A: scan every change in CI with Pro.

Download with Pro
SKILL.md
---
name: ata-gh-pregnancy-discontinuation
description: Suggests discontinuing growth hormone (GH) replacement during pregnancy due to lack of clear evidence for efficacy or safety and placental GH production. Triggers include managing a pregnant patient on GH replacement.
---

# Discontinue growth hormone replacement during pregnancy

## STEP 1 — Gather Information
Confirm pregnancy via clinical assessment or laboratory test (e.g., serum hCG, ultrasound) and document current GH replacement dose and frequency. **Action:** Record pregnancy status and GH prescription.

## STEP 2 — Rule In / Rule Out
If the patient is pregnant and currently prescribed GH replacement, rule in for discontinuation; otherwise, rule out and maintain current therapy. **Decision:** Proceed to discontinuation if ruled in.

## STEP 3 — Classify or Stratify
Assess for any acute endocrine emergencies (e.g., hypoglycemia, hypotension) that might warrant caution; if none, classify as suitable for discontinuation. **Action:** Classify patient as appropriate for GH cessation.

## STEP 4 — Decide
Discontinue GH replacement immediately. Advise patient to report any new symptoms (e.g., fatigue, weakness) and arrange follow‑up in 4–6 weeks to reassess clinical status. **Decision:** Stop GH and plan monitoring.

## Clinical Guardrails / Mimics / Pitfalls
Do not continue GH based on theoretical benefit; placental GH production may mask deficiency. Avoid mistaking normal pregnancy symptoms (fatigue, edema) for GH deficiency worsening. Do not delay discontinuation awaiting symptom improvement without evidence. Monitor other pituitary axes (thyroid, cortisol) as their needs may change in pregnancy.

## Concrete Clinical Example
A 28‑year‑old woman with adult GH deficiency on 0.3 mg/day GH presents at 12 weeks gestation. After confirming pregnancy, GH is stopped. She reports no worsening of fatigue or body composition changes at 20‑week follow‑up.

**Source:** Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2016-2118

Attribution

Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.

Comments

Loading comments…

Newsletter

Get the weekly list of safe new skills, and the ones we pulled.